Cytek Biosciences enters severance and consulting agreements with former CLO Valerie Barnett

Cytek Biosciences, Inc.

Valerie Barnett's CLO role terminated June 29, 2026; severance lump sum of $365,775.12 plus COBRA through April 30, 2027.
If change in control occurs within 3 months, enhanced severance: 18 months base salary plus 2026 bonus target, COBRA through Jan 31, 2028, and equity acceleration.
Consulting agreement from July 10 to Aug 31, 2026 at $1,000/hour, max 10 hours/week, with continued equity vesting during term.
Previously granted equity awards under 2021 Equity Incentive Plan continue to vest subject to Continuous Service during consulting.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.